113 related articles for article (PubMed ID: 31450834)
1. Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activators.
Jenkins DP; Yu W; Brown BM; Løjkner LD; Wulff H
Assay Drug Dev Technol; 2013; 11(9-10):551-60. PubMed ID: 24351043
[TBL] [Abstract][Full Text] [Related]
2. Intracellular acidity impedes KCa3.1 activation by Riluzole and SKA-31.
Cozzolino M; Panyi G
Front Pharmacol; 2024; 15():1380655. PubMed ID: 38638868
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-Dependent Hyperpolarization (EDH) in Hypertension: The Role of Endothelial Ion Channels.
Goto K; Ohtsubo T; Kitazono T
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361737
[TBL] [Abstract][Full Text] [Related]
4. Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award.
Chakraborty S; Mandal J; Yang T; Cheng X; Yeo JY; McCarthy CG; Wenceslau CF; Koch LG; Hill JW; Vijay-Kumar M; Joe B
Hypertension; 2020 Jun; 75(6):1386-1396. PubMed ID: 32336227
[TBL] [Abstract][Full Text] [Related]
5. Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Sadowska O; Kozłowski M; Kusaczuk M; Kasacka I; Malinowska B
J Hypertens; 2020 May; 38(5):896-911. PubMed ID: 31800399
[TBL] [Abstract][Full Text] [Related]
6. Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Kusaczuk M; Harasim-Symbor E; Biernacki M; Kasacka I; Malinowska B
Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832902
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids-A New Perspective in Adjuvant Therapy for Pulmonary Hypertension.
Krzyżewska A; Baranowska-Kuczko M; Mińczuk K; Kozłowska H
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576212
[TBL] [Abstract][Full Text] [Related]
8. Effect of the KCa3.1 blocker, senicapoc, on cerebral edema and cardiovascular function after cardiac arrest - A randomized experimental rat study.
Hansen FB; Secher N; Mattson T; Løfgren B; Simonsen U; Granfeldt A
Resusc Plus; 2021 Jun; 6():100111. PubMed ID: 34223371
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pancreatic microcirculation profiles in spontaneously hypertensive rats and Wistar-kyoto rats by laser doppler and wavelet transform analysis.
Song X; Li Y; Wang B; Liu M; Zhang J; Li A; Zhang H; Xiu R
Physiol Res; 2020 Dec; 69(6):1039-1049. PubMed ID: 33129246
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Microcirculation Profiles in the Progression of Hypertension in Spontaneously Hypertensive Rats.
Liu M; Song X; Wang B; Li Y; Li A; Zhang J; Zhang H; Xiu R
Am J Hypertens; 2021 Feb; 34(1):100-109. PubMed ID: 33057586
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats.
Sadowska O; Baranowska-Kuczko M; Gromotowicz-Popławska A; Biernacki M; Kicman A; Malinowska B; Kasacka I; Krzyżewska A; Kozłowska H
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992900
[TBL] [Abstract][Full Text] [Related]
12. The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on K
Kloza M; Baranowska-Kuczko M; Malinowska B; Karpińska O; Harasim-Symbor E; Kasacka I; Kozłowska H
Vascul Pharmacol; 2017 Dec; 99():65-73. PubMed ID: 29038048
[TBL] [Abstract][Full Text] [Related]
13. SKA-31, an activator of endothelial Ca
Khaddaj-Mallat R; Mathew John C; Braun AP
Eur J Pharmacol; 2018 Jul; 831():60-67. PubMed ID: 29753043
[TBL] [Abstract][Full Text] [Related]
14. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H
Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic targeting of endothelial Ca
Mathew John C; Khaddaj Mallat R; George G; Kim T; Mishra RC; Braun AP
Channels (Austin); 2018 Jan; 12(1):126-136. PubMed ID: 29577810
[TBL] [Abstract][Full Text] [Related]
16. Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.
Grgic I; Kaistha BP; Hoyer J; Köhler R
Br J Pharmacol; 2009 Jun; 157(4):509-26. PubMed ID: 19302590
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of
Kloza M; Baranowska-Kuczko M; Toczek M; Kusaczuk M; Sadowska O; Kasacka I; Kozłowska H
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450834
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
